Search results
I'm a trichologist - the best ingredients to look for to promote hair growth
The US Sun· 2 hours agoFROM reducing frizz to stimulating growth, a trichologist has revealed the best ingredients for...
Selena Gomez explains why she disabled public Instagram comments
TODAY via Yahoo News· 18 hours agoThey fuss about everything. She added: "I felt empowered by doing that, by saying, 'This is just for...
Earnings call: AbbVie projects robust growth and diversified pipeline
Investing.com· 1 day agoWith a growth platform that accounts for 80% of AbbVie's business, the company saw mid-teens growth...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 20 hours agoIs CRISPR stock a buy? CRISPR remains on track to start clinical trials for CTX112, a gene-editing...
Myalgia (Muscle Pain)
Health via Yahoo News· 7 days agoDaily life stress or tension to more debilitating health conditions can all cause muscle pain and affect your quality of life. Myalgia is often due to...
QC Running Festival set for Memorial Day
WHBF Davenport via Yahoo Sports· 5 days agoThe fourth annual Quad Cities Running Festival will be Memorial Day, Monday, May 27, in support of the local non-profit LIVEFIT with Lupus, according to...
In RA Treatment, Don't Overlook Underlying CV Risks
Medscape· 6 hours agoPatients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated...
Exagen (NASDAQ:XGN) PT Raised to $7.00 at Cantor Fitzgerald
ETF DAILY NEWS· 7 hours agoExagen (NASDAQ:XGN – Get Free Report) had its price target hoisted by equities research analysts at Cantor Fitzgerald from $5.00 to $7.00 in a report released on Tuesday, Benzinga reports. The ...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. | The Motley Fool
The Motley Fool· 20 hours agoLacking a big milestone payment like the one in Q1 2023, CRISPR's revenue plummeted 99.5% year over...
Earnings call: Fate Therapeutics reports on clinical progress and finances By Investing.com
Investing.com· 3 days agoThe company's FT819 CAR T-cell therapy showed promise for B-cell-mediated autoimmune diseases, with...
